Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Net Cash Flow (2021 - 2025)

Cingulate's (CINGW) quarterly Net Cash Flow came in at $4.8 million in Q4 2025, up 122.68% on a YoY basis from $2.2 million in Q4 2024, and up 273.82% quarter-over-quarter from -$2.8 million in Q3 2025.

Analysis

Cingulate (CINGW) Net Cash Flow (2021 - 2025) Analysis & Trends

Cingulate (CINGW) has reported Net Cash Flow for 5 consecutive years, with $4.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 122.68% year-over-year to $4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$1.3 million (down 110.3% YoY), and the FY2025 full-year result was -$1.3 million, down 110.35% from the prior year.
  • Net Cash Flow improved to $4.8 million in Q4 2025 per CINGW's latest filing, from -$2.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $14.6 million in Q4 2021 and bottomed at -$4.4 million in Q4 2022.
  • Historically, Net Cash Flow has averaged $488081.8 across 5 years, with a median of -$501143.5 in 2021.
  • The sharpest annual moves came in 2022 and 2024: Net Cash Flow slumped 1971.64% in 2022, then soared 490.24% in 2024.
  • Over 5 years, Net Cash Flow stood at $14.6 million in 2021, then plunged by 130.45% to -$4.4 million in 2022, then surged by 56.44% to -$1.9 million in 2023, then jumped by 212.27% to $2.2 million in 2024, then jumped by 122.68% to $4.8 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $4.8 million, -$2.8 million, and -$612858.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn -1.27 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn -2.82 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 757.00 Mn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn -722.00 Mn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 918.27 Mn
7 Revolution Medicines 44.26 Bn 44.26 Bn - 374.50 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 521.33 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 523.50 Mn
10 Cingulate 100,214.03 100,214.03 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.83 Mn
Sep 30, 2025 -2.78 Mn
Jun 30, 2025 -612,858.00
Mar 31, 2025 -2.69 Mn
Dec 31, 2024 2.17 Mn
Sep 30, 2024 9.66 Mn
Jun 30, 2024 -732,903.00
Mar 31, 2024 1.06 Mn
Dec 31, 2023 -1.93 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 -1.39 Mn
Mar 31, 2023 -3.62 Mn
Dec 31, 2022 -4.44 Mn
Sep 30, 2022 1.60 Mn
Jun 30, 2022 -4.42 Mn
Mar 31, 2022 -3.88 Mn
Dec 31, 2021 14.58 Mn
Sep 30, 2021 871,100.00
Jun 30, 2021 236,072.00
Mar 31, 2021 -389,429.00